Rule 144 Notice — SentinelOne Insider Sale of 3,089 Class A Shares
Rhea-AI Filing Summary
Form 144 notice for SentinelOne, Inc. (S): This filing notifies a proposed sale of 3,089 Class A Common shares through Raymond James & Associates on or about 10/01/2025, with an aggregate market value of $52,513.00 and listing on the NYSE. The filer reports that those securities were originally acquired on 07/02/2021 in a public stock purchase from SentinelOne, Inc., and the filing notes 107,025 shares as the amount previously acquired by the account. The issuer's total shares outstanding are listed as 324,760,095. The form also discloses two recent sales by Insight Partners Fund X (Cayman) Follow-On Fund, L.P.: 4,602 shares sold on 07/07/2025 for $83,811.62 and 4,665 shares sold on 07/08/2025 for $85,977.82. The signer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 sale notice; modest planned disposition relative to total shares outstanding, with recent small secondary sales disclosed.
This Form 144 records a proposed brokered sale of 3,089 Class A shares valued at $52,513, originating from a 2021 public purchase. Two nearby transactions by Insight Partners Fund X (Cayman) show modest dispositions totaling 9,267 shares and roughly $169,789 in gross proceeds. Given the issuer's 324.76 million shares outstanding, these amounts represent a very small fraction of the float and appear routine rather than market-moving. The filing contains standard Rule 144 certifications but does not disclose any new operational or financial information about the company.
TL;DR: Filing meets Rule 144 disclosure requirements and includes the required certification; no red flags in presentation.
The notice identifies the broker, planned sale date, acquisition provenance, and recent related sales, and includes the signer’s representation about material non-public information and trading-plan language. The record shows proper aggregation of related sales by the named fund. There is no indication in the filing of procedural or disclosure irregularities. The document is administrative in nature and does not introduce governance issues or regulatory concerns on its face.